Results 191 to 200 of about 123,600 (352)

Seven-Year Course of Hypoplastic Myelodysplastic Syndrome Unmasked by Secondary and Neurological Syphilis. [PDF]

Mediterr J Hematol Infect Dis
Turunç A, Dinçyürek HD, Güvenç B.
europepmc   +1 more source

Usefulness of Ustekinumab for Treating a Case of Myelodysplastic Syndrome-associated Inflammatory Bowel Disease

, 2019
Masashi Kono, Toshiharu Sakurai, Kazuki Okamoto, Tomoyuki Nagai, Yoriaki Komeda, Hiroshi Kashida, Kosuke Minaga, Ken Kamata, Mamoru Takenaka, Satoru Hagiwara, Tomohiro Watanabe, Naoshi Nishida, Eisuke Enoki, Hiroaki Inoue, Itaru Matsumura, Masatoshi Kudo   +15 more
openalex   +2 more sources

Altered splicing and cytoplasmic levels of tRNA synthetases in SF3B1-mutant myelodysplastic syndromes as a therapeutic vulnerability [PDF]

, 2019
Fabio G. Liberante, Katrina M. Lappin, Eliana M. Barros, Jekaterina Vohhodina, Florian Grebien, Kienan I. Savage, Ken Mills   +6 more
openalex   +1 more source

Supplementary Figure from Convergent Clonal Evolution of Signaling Gene Mutations Is a Hallmark of Myelodysplastic Syndrome Progression

, 2023
Andrew J. Menssen, Ajay Khanna, Christopher A. Miller, Sridhar Nonavinkere Srivatsan, Gue Su Chang, Jin Shao, Joshua D. Robinson, Michele O’Laughlin, Catrina C. Fronick, Robert S. Fulton, Kimberly Brendel, Sharon E. Heath, Raya Saba, John S. Welch, David H. Spencer, Jacqueline E. Payton, Peter Westervelt, John F. DiPersio, Daniel C. Link, Matthew J. Schuelke, Meagan A. Jacoby, Eric J. Duncavage, Timothy J. Ley, Matthew J. Walter   +23 more
openalex   +1 more source

Acute Eruption in a Child With Acute Lymphoblastic Leukemia

Pediatric Dermatology, EarlyView.
L. Parra‐Navarro, N. Planella‐Fontanillas, C. Prat   +2 more
wiley   +1 more source

Retrospective Evaluation of Dual Specialty Ports in Therapeutic Apheresis

Journal of Clinical Apheresis, Volume 41, Issue 3, June 2026.
ABSTRACT Dual specialty ports were evaluated for safety and efficacy in therapeutic apheresis by analyzing outcomes across 97 port placement events in 88 patients, focusing on two configurations: dual Bard PowerFlow (BP2) and a combination of Bard PowerFlow with AngioDynamics SmartPort (BP + AD).
Mugtaba Swar‐Eldahab, Barnabas Obeng‐Gyasi, Paul Haste, Matthew Krosin   +3 more
wiley   +1 more source

Management of iron overload in adult myelodysplastic syndrome. [PDF]

Hematology Am Soc Hematol Educ Program
Leitch HA, Buckstein R.
europepmc   +1 more source

Epigenetics of TET2 loss in myelodysplastic syndromes

, 2015
Allegra M. Lord
openalex   +1 more source

Limited numbers of apoptotic cells in fresh paraffin embedded bone marrow samples of patients with myelodysplastic syndrome

, 2004
S Brada, Arjan A. van de Loosdrecht, J Koudstaal, J. Th. M. de Wolf, Edo Vellenga   +4 more
openalex   +2 more sources

Hypermethylation of the VTRNA1-3 Promoter is Associated with Poor Outcome in Lower Risk Myelodysplastic Syndrome Patients [PDF]

, 2015
Alexandra S. Helbo, Marianne Bach Treppendahl, Derya Aslan, Konstantinos Dimopoulos, Cecilie Nandrup-Bus, Mette Holm, Mette Klarskov Andersen, Gangning Liang, Lasse S. Kristensen, Kirsten Grønbæk   +9 more
openalex   +1 more source